Cerebral Thrombosis: A Neurogenetic Approach
Christos Yapijakis1,2,3
1Department of Oral and Maxillofacial Surgery, School of Medicine, University of Athens, Attikon Hospital, Athens, Greece. cyapi@med.uoa.gr.
Cerebral venous thrombosis (CVT) is a serious condition with high mortality if untreated. Early diagnosis and treatment, alongside preventative measures like healthy living and genetic analysis, significantly improve outcomes.
Area of Science:
- Neurology
- Vascular Medicine
- Genetics
Background:
- Cerebral venous thrombosis (CVT) is a complex neurological disorder.
- CVT presents with diverse clinical symptoms including headache, seizures, and coma.
- Untreated CVT carries a high mortality rate of up to 50%.
Purpose of the Study:
- To highlight the severity and clinical spectrum of Cerebral Venous Thrombosis.
- To emphasize the critical importance of timely and appropriate treatment for CVT.
- To outline feasible strategies for the prevention of CVT.
Main Methods:
- Review of clinical manifestations and outcomes of CVT.
- Analysis of mortality rates in treated versus untreated CVT cases.
- Identification of preventative measures including lifestyle, genetic counseling, and anticoagulation.
Main Results:
- Properly treated CVT mortality rate decreases significantly to 10%.
- Preventative strategies are identified as effective in reducing CVT incidence.
- Early intervention dramatically improves patient prognosis.
Conclusions:
- Cerebral venous thrombosis requires prompt medical attention to reduce mortality.
- Preventative measures, including genetic analysis and lifestyle modifications, are crucial for managing CVT risk.
- Effective treatment strategies can transform CVT outcomes from fatal to manageable.
More Related Videos
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
06:12Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots
Published on: July 21, 2023
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pharmacogenomics: Identification of New Drug Targets
